Sangamo Therapeutics, Inc.
Methods and compositions for the treatment of Fabry disease
Last updated:
Abstract:
Nucleases and methods of using these nucleases for inserting a sequence encoding a therapeutic .alpha.-Gal A protein such as an enzyme into a cell, thereby providing proteins or cell therapeutics for treatment and/or prevention of Fabry disease.
Status:
Grant
Type:
Utility
Filling date:
19 Oct 2017
Issue date:
11 Jan 2022